0.230
0.00 (0.00%)
| Penutupan Terdahulu | 0.230 |
| Buka | 0.230 |
| Modal Pasaran | 34,272,300 |
| Harga / Pendapatan (P/E TTM) | 23.00 |
| Harga / Jualan (P/S) | 4.81 |
| Harga / Buku (P/B) | 3.05 |
| Julat 52 Minggu | |
| Hasil Dividen (DY TTM) | 34.78% |
| Margin Keuntungan | 37.97% |
| Margin Operasi (TTM) | 45.96% |
| EPS Cair (TTM) | 0.010 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 39.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 565.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.69% |
| Nisbah Semasa (MRQ) | 4.55 |
| Aliran Tunai Operasi (OCF TTM) | 5.50 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 6.62 M |
| Pulangan Atas Aset (ROA TTM) | 19.34% |
| Pulangan Atas Ekuiti (ROE TTM) | 30.89% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Engineering & Construction (MY) | Menaik | Bercampur |
| Engineering & Construction (Global) | Menaik | Menaik | |
| Stok | NPS | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | NA |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 1.33 |
|
Nova Pharma Solutions Bhd is principally engaged in the business of providing technical documentation, validation, and project execution in the pharmaceutical and biological industries. The group focuses on the design and building phase of pharmaceutical and biotechnology plants, providing engineering solutions ranging from pre-design (feasibility study and site selection), design (conceptual design, basic design, and detailed design), post-design (tendering, procurement and site supervision) to other supporting activities (GMP documents review and gap analysis and assessment). Its reportable segments include Post Design fee, which derives maximum revenue, Design fee, EPCC, and Other support fees. Geographically, the group generates a majority of its revenue from Malaysia. |
|
| Sektor | Industrials |
| Industri | Engineering & Construction |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 73.44% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Hasil Dividen (DY TTM) | 34.78% |
| Purata Hasil Dividen 3T | 1.96% |
| Jangkaan Pembayaran Dividen Seterusnya | Dec 2026 |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 28 Nov 2025 | 21 Nov 2025 | 26 Dec 2025 | 0.08 Tunai |
| 11 Dec 2024 | 25 Nov 2024 | 27 Dec 2024 | 0.006 Tunai |
| 29 Aug 2023 | 21 Aug 2023 | 15 Sep 2023 | 0.005 Tunai |
| 01 Sep 2022 | 23 Aug 2022 | 15 Sep 2022 | 0.0025 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2025 | 0.080 | 1 | 34.78 |
| 2024 | 0.006 | 1 | 2.61 |
| 2023 | 0.005 | 1 | 2.17 |
| 2022 | 0.003 | 1 | 1.09 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |